260 related articles for article (PubMed ID: 24292256)
1. An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease.
Pienaar IS; Harrison IF; Elson JL; Bury A; Woll P; Simon AK; Dexter DT
Brain Struct Funct; 2015 Jan; 220(1):479-500. PubMed ID: 24292256
[TBL] [Abstract][Full Text] [Related]
2. Temporal-Spatial Profiling of Pedunculopontine Galanin-Cholinergic Neurons in the Lactacystin Rat Model of Parkinson's Disease.
Elson JL; Kochaj R; Reynolds R; Pienaar IS
Neurotox Res; 2018 Jul; 34(1):16-31. PubMed ID: 29218504
[TBL] [Abstract][Full Text] [Related]
3. Pedunculopontine cell loss and protein aggregation direct microglia activation in parkinsonian rats.
Elson JL; Yates A; Pienaar IS
Brain Struct Funct; 2016 May; 221(4):2319-41. PubMed ID: 25989851
[TBL] [Abstract][Full Text] [Related]
4. A non-cholinergic neuronal loss in the pedunculopontine nucleus of toxin-evoked parkinsonian rats.
Pienaar IS; van de Berg W
Exp Neurol; 2013 Oct; 248():213-23. PubMed ID: 23769975
[TBL] [Abstract][Full Text] [Related]
5. Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease.
Bensaid M; Michel PP; Clark SD; Hirsch EC; François C
Exp Neurol; 2016 Jan; 275 Pt 1():209-19. PubMed ID: 26571193
[TBL] [Abstract][Full Text] [Related]
6. DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian Rats.
Sharma PK; Wells L; Rizzo G; Elson JL; Passchier J; Rabiner EA; Gunn RN; Dexter DT; Pienaar IS
Neurotherapeutics; 2020 Jul; 17(3):1120-1141. PubMed ID: 31965550
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson's disease.
Pienaar IS; Gartside SE; Sharma P; De Paola V; Gretenkord S; Withers D; Elson JL; Dexter DT
Mol Neurodegener; 2015 Sep; 10():47. PubMed ID: 26394842
[TBL] [Abstract][Full Text] [Related]
8. Nigral injection of a proteasomal inhibitor, lactacystin, induces widespread glial cell activation and shows various phenotypes of Parkinson's disease in young and adult mouse.
Savolainen MH; Albert K; Airavaara M; Myöhänen TT
Exp Brain Res; 2017 Jul; 235(7):2189-2202. PubMed ID: 28439627
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial abnormality associates with type-specific neuronal loss and cell morphology changes in the pedunculopontine nucleus in Parkinson disease.
Pienaar IS; Elson JL; Racca C; Nelson G; Turnbull DM; Morris CM
Am J Pathol; 2013 Dec; 183(6):1826-1840. PubMed ID: 24099985
[TBL] [Abstract][Full Text] [Related]
10. Effect of neurotoxic lesion of pedunculopontine nucleus in nigral and striatal redox balance and motor performance in rats.
Jimenez-Martin J; Blanco-Lezcano L; González-Fraguela ME; Díaz-Hung ML; Serrano-Sánchez T; Almenares JL; Francis-Turner L
Neuroscience; 2015 Mar; 289():300-14. PubMed ID: 25596320
[TBL] [Abstract][Full Text] [Related]
11. Altered neuronal activity in the pedunculopontine nucleus: An electrophysiological study in a rat model of Parkinson's disease.
Geng X; Xie J; Wang X; Wang X; Zhang X; Hou Y; Lei C; Li M; Qu Q; He T; Han H; Yao X; Wang M
Behav Brain Res; 2016 May; 305():57-64. PubMed ID: 26924016
[TBL] [Abstract][Full Text] [Related]
12. The anterior and posterior pedunculopontine tegmental nucleus are involved in behavior and neuronal activity of the cuneiform and entopeduncular nuclei.
Jin X; Schwabe K; Krauss JK; Alam M
Neuroscience; 2016 May; 322():39-53. PubMed ID: 26880033
[TBL] [Abstract][Full Text] [Related]
13. Gait disorders in parkinsonian monkeys with pedunculopontine nucleus lesions: a tale of two systems.
Grabli D; Karachi C; Folgoas E; Monfort M; Tande D; Clark S; Civelli O; Hirsch EC; François C
J Neurosci; 2013 Jul; 33(29):11986-93. PubMed ID: 23864685
[TBL] [Abstract][Full Text] [Related]
14. Selective cholinergic depletion of pedunculopontine tegmental nucleus aggravates freezing of gait in parkinsonian rats.
Xiao H; Li M; Cai J; Li N; Zhou M; Wen P; Xie Z; Wang Q; Chang J; Zhang W
Neurosci Lett; 2017 Oct; 659():92-98. PubMed ID: 28803956
[TBL] [Abstract][Full Text] [Related]
15. Low-frequency stimulation of the pedunculopontine nucleus affects gait and the neurotransmitter level in the ventrolateral thalamic nucleus in 6-OHDA Parkinsonian rats.
Wen P; Li M; Xiao H; Ding R; Chen H; Chang J; Zhou M; Yang Y; Wang J; Zheng W; Zhang W
Neurosci Lett; 2015 Jul; 600():62-8. PubMed ID: 26054938
[TBL] [Abstract][Full Text] [Related]
16. Retrograde dopaminergic neuron degeneration following intrastriatal proteasome inhibition.
Miwa H; Kubo T; Suzuki A; Nishi K; Kondo T
Neurosci Lett; 2005 May 20-27; 380(1-2):93-8. PubMed ID: 15854758
[TBL] [Abstract][Full Text] [Related]
17. Unilateral lesion of the pedunculopontine nucleus induces hyperactivity in the subthalamic nucleus and substantia nigra in the rat.
Breit S; Lessmann L; Benazzouz A; Schulz JB
Eur J Neurosci; 2005 Nov; 22(9):2283-94. PubMed ID: 16262666
[TBL] [Abstract][Full Text] [Related]
18. Pedunculopontine cholinergic cell loss in hallucinating Parkinson disease patients but not in dementia with Lewy bodies patients.
Hepp DH; Ruiter AM; Galis Y; Voorn P; Rozemuller AJ; Berendse HW; Foncke EM; van de Berg WD
J Neuropathol Exp Neurol; 2013 Dec; 72(12):1162-70. PubMed ID: 24226265
[TBL] [Abstract][Full Text] [Related]
19. Glutamatergic and cholinergic pedunculopontine neurons innervate the thalamic parafascicular nucleus in rats: changes following experimental parkinsonism.
Barroso-Chinea P; Rico AJ; Conte-Perales L; Gómez-Bautista V; Luquin N; Sierra S; Roda E; Lanciego JL
Brain Struct Funct; 2011 Nov; 216(4):319-30. PubMed ID: 21499800
[TBL] [Abstract][Full Text] [Related]
20. Altered neuronal activity relationships between the pedunculopontine nucleus and motor cortex in a rodent model of Parkinson's disease.
Aravamuthan BR; Bergstrom DA; French RA; Taylor JJ; Parr-Brownlie LC; Walters JR
Exp Neurol; 2008 Oct; 213(2):268-80. PubMed ID: 18601924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
